Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Papp

Showing results (361-370 of 393) with videos related to

Pageof 40
Sort By:
Mbio|December 13, 2018
Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosaMelissa D Barnes, Magdalena A Taracila, Joseph D Rutter, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor CombinationKrisztina M Papp-Wallace, Christopher R Bethel, Jocelyne Caillon, et al.
Mbio|November 2, 2017
<i>Klebsiella pneumoniae</i> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein EngineeringMelissa D Barnes, Marisa L Winkler, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2025
<i>Burkholderia pseudomallei</i> PenI β-lactamase and variants are potently inhibited by taniborbactamMaria F Mojica, Scott A Becka, Mitchell Edwards, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2007
NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's diseaseT Molnar, P Hofner, F Nagy, et al.
Journal of Wildlife Diseases|June 5, 2018
PREVALENCE AND RISK FACTORS OF TRICHOMONAS GALLINAE AND TRICHOMONOSIS IN GOLDEN EAGLE ( AQUILA CHRYSAETOS) NESTLINGS IN WESTERN NORTH AMERICABenjamin M Dudek, Michael N Kochert, Joseph G Barnes, et al.
The Journal of Antimicrobial Chemotherapy|November 16, 2013
A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenemsKrisztina M Papp-Wallace, Susana Mallo, Christopher R Bethel, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2022
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-AvibactamT A Alsenani, S L Viviani, V Kumar, et al.
ACS Infectious Diseases|March 8, 2017
Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis PatientsKrisztina M Papp-Wallace, Scott A Becka, Elise T Zeiser, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
Analysis of the Structure and Function of FOX-4 CephamycinaseS T Lefurgy, V N Malashkevich, J T Aguilan, et al.
Pageof 40

Showing results (361-370 of 393) with videos related to

Sort By:
Pageof 40
Mbio|December 13, 2018
Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosaMelissa D Barnes, Magdalena A Taracila, Joseph D Rutter, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2019
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam-β-Lactamase Inhibitor CombinationKrisztina M Papp-Wallace, Christopher R Bethel, Jocelyne Caillon, et al.
Mbio|November 2, 2017
<i>Klebsiella pneumoniae</i> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein EngineeringMelissa D Barnes, Marisa L Winkler, Magdalena A Taracila, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2025
<i>Burkholderia pseudomallei</i> PenI β-lactamase and variants are potently inhibited by taniborbactamMaria F Mojica, Scott A Becka, Mitchell Edwards, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 30, 2007
NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's diseaseT Molnar, P Hofner, F Nagy, et al.
Journal of Wildlife Diseases|June 5, 2018
PREVALENCE AND RISK FACTORS OF TRICHOMONAS GALLINAE AND TRICHOMONOSIS IN GOLDEN EAGLE ( AQUILA CHRYSAETOS) NESTLINGS IN WESTERN NORTH AMERICABenjamin M Dudek, Michael N Kochert, Joseph G Barnes, et al.
The Journal of Antimicrobial Chemotherapy|November 16, 2013
A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenemsKrisztina M Papp-Wallace, Susana Mallo, Christopher R Bethel, et al.
Antimicrobial Agents and Chemotherapy|March 28, 2022
Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-AvibactamT A Alsenani, S L Viviani, V Kumar, et al.
ACS Infectious Diseases|March 8, 2017
Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis PatientsKrisztina M Papp-Wallace, Scott A Becka, Elise T Zeiser, et al.
Antimicrobial Agents and Chemotherapy|November 4, 2015
Analysis of the Structure and Function of FOX-4 CephamycinaseS T Lefurgy, V N Malashkevich, J T Aguilan, et al.
Pageof 40